Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
TSVT

TSVT - 2seventy bio, Inc. Stock Price, Fair Value and News

$170.000.00 (0.00%)
Market Closed

6/100

TSVT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

6/100

TSVT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$136

Target 3M

$153

Target 6M

$144.5

TSVT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TSVT Price Action

Trailing 12 Months

6672.9%

TSVT RSI Chart

TSVT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TSVT Valuation

Market Cap

9.0B

Price/Earnings (Trailing)

-2.2K

Price/Sales (Trailing)

187.1

EV/EBITDA

3.5K

Price/Free Cashflow

-166.99

TSVT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$136

Target 3M

$153

Target 6M

$144.5

TSVT Fundamentals

TSVT Revenue

Revenue (TTM)

48.4M

TSVT Earnings

Earnings (TTM)

-4.1M

TSVT Profitability

EBT Margin

-8.46%

Return on Equity

-1.91%

Return on Assets

-0.85%

Free Cashflow Yield

-0.6%

TSVT Investor Care

Shares Dilution (1Y)

3.55%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202548.4M000
202471.2M44.1M45.6M37.9M
2023124.7M147.3M145.9M100.4M
202251.0M57.2M51.4M91.5M
2021199.7M151.3M102.9M54.5M
202000146.2M248.1M
201900044.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About 2seventy bio, Inc.

TSVT
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
 CEO
 WEBSITE2seventybio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES425

2seventy bio, Inc. Frequently Asked Questions

TSVT is the stock ticker symbol of 2seventy bio, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of 2seventy bio, Inc. is 9.05 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check TSVT's fair value in chart for subscribers.

The fair value guage provides a quick view whether TSVT is over valued or under valued. Whether 2seventy bio, Inc. is cheap or expensive depends on the assumptions which impact 2seventy bio, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TSVT.

As of Tue Jan 27 2026, TSVT's PE ratio (Price to Earnings) is -2211.4 and Price to Sales (PS) ratio is 187.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TSVT PE ratio will change depending on the future growth rate expectations of investors.